Medical Perfusion Technology Market Size, Share Global Analysis Report, , 2021 – 2026

Industry Insights

[194+ Pages Report] We at Facts & Factors estimate the revenue for the global Medical Perfusion Technology Market to be valued at USD 905.50 Million by the end of 2026, up from a base value of USD 750.15 Million in 2020, at a CAGR of 5.6%.

Market Overview

Medical perfusion is the anatomical study of the lungs pathway and the interconnecting respiratory organs. These organs are a pivotal part of the human body and need excessive care when damaged or during surgical procedures. Special devices are connected to the required orifices in order to mimic the function of these organs in case of irregular situations. These devices regulate blood flow to the organs and cater levels of oxygen and carbon dioxide in the blood levels using a heart-lung (bypass) machine.

Industry Growth Factors

The major driving forces behind the extensive growth of the medical perfusion technology market can be marked down to an increasing prevalence of failing organ systems and rising demand for organs for transplantation needs over the forecast period. Increase of chronic diseases among the aging and advanced population will further boost the growth of the medical perfusion technology market. Extensive development in the sector has led to the birth of advanced features in the sector such as organ preservation within these devices. This added functionality helps in pushing the boundaries of the growth of the market on a global scale. Moreover, prolonged shelf life of such organs opens new pathways for revenue generation during the forecast period. However, the unavailability of skilled doctors and medical practitioners who possess the required knowledge might hamper the growth of the market to a certain extent.

Segmentation Analysis

The global medical perfusion technology market can be segmented on the basis of technology, organ type, components, and regions.

On the basis of technology, the global medical perfusion technology market can be divided into hypothermic machine perfusion and normothermic machine perfusion. The sector of hypothermic machine perfusion is expected to recoup the largest market value over the forecast period in terms of revenue collected and sales. These devices serves as a viable alternative for cold storage facilities and also serves as a station for recovery grafts after post-op conditions. Additionally, research studies have indicated more functionality in other organs such the liver by providing a continuous flow of antioxidants and metabolic substrates in order to get rid of the liver of toxins and cytokines. On the basis of organ type, the global medical perfusion technology market can be broken down into heart, lung, kidney, liver, and others. The segment related to kidney transplants will account for the largest market share during the forecast. The most common functionality of medical perfusion technology devices was preservation of kidney which has led to the dominant position of the latter. The heart segment is expected to rise at a significant pace owing to extensive research and developmental measures undertaken to develop devices for preservation of heart at an optimal price. On the basis of component, the global medical perfusion technology market can be bifurcated into perfusion pumps, oxygenators, heart-lung machines, monitoring systems, cannular, and others. The oxygenators segment is expected to witness the largest market share during the forecast owing to the functionality and the current trend of medical requirements. Additional factors that can be credited to the dominant position of the segment can be credited to an increase in cardiovascular surgeries, liver transplantation, and kidney transplantation.

Regional Analysis

North America is expected to witness the highest market growth in terms of revenue collection over the forecast period. Recent studies indicate a low number of organs available in accordance with the current requirements. The growing disparity between demand and supply prompts the growth of the medical perfusion technology market to grow at unprecedented rate. Additional factors that are responsible for the growth of the market in the region can be credited to the extensive government funding, increased awareness about medical perfusion among consumers, increased research and developmental measures, and widened consumer spending. Asia-Pacific is expected to witness the fastest growing CAGR within the forecast period.

Report Scope

Competitive Players

The key participants in the global medical perfusion technology market are :

• XVIVO Perfusion AB.
• Organ Assist B.V.
• Organ Recovery Systems
• Organ Transport Systems
• Waters Medical Systems
• Paragonix Technologies
• TransMedics Inc.
• OrganOx Limited
• Bridge to Life Ltd.
• Getinge AB
• Medtronic
• LivaNova PLC
• XENIOS AG.

By Technology Segment Analysis

• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion

By Organ Type Segment Analysis

• Heart
• Lung
• Kidney
• Liver
• Others

By Component Segment Analysis

• Perfusion Pumps
• Oxygenators
• Heart-Lung Machines
• Monitoring Systems
• Cannular
• Others

By Regional Segment Analysis

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of MEA